TY - JOUR ID - 153312 TI - Vitamin D in Mild to Moderate COVID-19: A Retrospective Cross-Sectional Study JO - Journal of Medicinal and Chemical Sciences JA - JMCS LA - en SN - AU - Sahraeai, Reza AU - Hooshmand, Farhang AU - Ghaedi, Mojtaba AU - Shafa, Shahram AU - Eftekharian, Fatemeh AU - Farrokhi, Samira AD - Research Center for Non.Communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran Y1 - 2023 PY - 2023 VL - 6 IS - 1 SP - 55 EP - 61 KW - SARS-CoV-2 KW - Vitamin D KW - COVID-19 KW - clinical outcomes DO - 10.26655/JMCHEMSCI.2023.1.7 N2 - Background: Vitamin D linkage with COVID-19 is investigated in many studies, but there is still no single summation. Thus, this study aimed to evaluate the relationship between Vitamin D levels and clinical characteristics of COVID-19.Methods: This was a retrospective cross-sectional study on floor admitted COVID-19 patients in the Jahrom province of Iran in 2020. The patients in this study were divided into different groups based on vitamin D status after the definitive diagnosis of COVID-19. Demographic and clinical characteristics of COVID-19 patients were analyzed based on the COVID-19 status. Results: Vitamin D levels were normal for almost half of the patients (51.7%) and the rest were insufficient (25.9%) or deficient (22.4%). Serum vitamin D levels did not correlate with vital sign data and venous blood gas results (P> 0.05). Vitamin D status was not different among patients with different symptoms of COVID-19 (P> 0.05).Conclusion: Our results revealed that vitamin D levels is not correlated to clinical characteristics in COVID-19 patients. In addition, well-designed studies with a good sample size are required to draw conclusions. UR - https://www.jmchemsci.com/article_153312.html L1 - https://www.jmchemsci.com/article_153312_92f8a171ecc715da1278540122eea369.pdf ER -